Association of genetic variations in aromatase gene with serum estrogen and estrogen/testosterone ratio in Chinese elderly men.
暂无分享,去创建一个
J. Woo | Jieying Jiang | C. Ohlsson | L. Vandenput | E. Orwoll | P. Leung | A. Kwok | T. Kwok | A. Eriksson | N. Tang | F. Chan | Jasmine K L Ching
[1] S. Cummings,et al. Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. , 2009, The Journal of clinical endocrinology and metabolism.
[2] T. Travison,et al. Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. , 2009, The Journal of clinical endocrinology and metabolism.
[3] B. Clarke. Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures , 2009 .
[4] N. Kondo,et al. Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers. , 2008, Japanese journal of clinical oncology.
[5] J. Murabito,et al. Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels. , 2008, The Journal of clinical endocrinology and metabolism.
[6] G. Risbridger,et al. Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling. , 2007, Journal of molecular endocrinology.
[7] D. Altshuler,et al. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. , 2007, Cancer research.
[8] S. Olson,et al. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. , 2007, American journal of epidemiology.
[9] J. Long,et al. Genetic Polymorphisms of the CYP19A1 Gene and Breast Cancer Survival , 2006, Cancer Epidemiology Biomarkers & Prevention.
[10] D. English,et al. Circulating Steroid Hormones and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[11] Karen Chuang,et al. High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. , 2005, BioTechniques.
[12] C. Haiman,et al. Common genetic variation in the sex steroid hormone-binding globulin (SHBG) gene and circulating shbg levels among postmenopausal women: the Multiethnic Cohort. , 2005, The Journal of clinical endocrinology and metabolism.
[13] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[14] B. Ponder,et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. , 2005, Journal of the National Cancer Institute.
[15] T. Key,et al. No association of polymorphisms in CYP17, CYP19, and HSD17-B1 with plasma estradiol concentrations in 1,090 British women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] J. Little,et al. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review. , 2004, American journal of epidemiology.
[17] M. Brandi,et al. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. , 2004, The Journal of clinical endocrinology and metabolism.
[18] Takashi Suzuki,et al. Organization of the human aromatase p450 (CYP19) gene. , 2004, Seminars in reproductive medicine.
[19] E. Jackson,et al. Cardiovascular Pharmacology of Estradiol Metabolites , 2004, Journal of Pharmacology and Experimental Therapeutics.
[20] Takashi Suzuki,et al. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[21] T. Key,et al. Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[22] P. Tiidus. Influence of Estrogen on Skeletal Muscle Damage, Inflammation, and Repair , 2003, Exercise and sport sciences reviews.
[23] J. Reichardt,et al. Hormones and prostate cancer: Current perspectives and future directions , 2002, The Prostate.
[24] T. Key,et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.
[25] C. Mantzoros,et al. Estrogens, Testosterone and Sex Hormone Binding Globulin in Relation to Liver Cancer in Men , 2001, Oncology.
[26] E. Jackson,et al. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. , 2001, American journal of physiology. Renal physiology.
[27] J. Gustafsson,et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] R Higuchi,et al. Single-tube genotyping without oligonucleotide probes. , 1999, Genome research.